Mechanisms, Risks, and New Treatment Options for Hyponatremia

Publisher： Karger

E-ISSN： 1421-9751|111|3|147-157

ISSN： 0008-6312

Source： Cardiology, Vol.111, Iss.3, 2008-04, pp. : 147-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heparin-induced thrombocytopenia: Pathophysiology and new treatment options

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 5-6, 2003-08 ,pp. : 289-294

Karger

Access to resources Recommend Favorite

Optimal treatment of hyponatremia in clinical practice

By Burst Volker   Witthus Marco   Grundmann Franziska   Müller Roman-Ulrich   Kubacki Torsten  

Clinical Practice, Vol. 10, Iss. 6, 2013-11 ,pp. : 737-749

Future Medicine

Access to resources Recommend Favorite

Non-Peptide Arginine-Vasopressin Antagonists (Vaptans) for the Treatment of Hyponatremia in Neurocritical Care: A New Alternative?

By Fields Jeremy  

Neurocritical Care, Vol. 11, Iss. 1, 2009-08 ,pp. : 1-4

Humana Press, Inc

Access to resources Recommend Favorite

Current Limitations in Treatment of Heart Failure: New Avenues and Treatment Options

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 13, Iss. S1, 2002-01 ,pp. : S53-S56

John Wiley & Sons Inc

Access to resources Recommend Favorite

New endoscopic and surgical treatment options for early esophageal adenocarcinoma

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 9, 2010-09 ,pp. : 1478-1484

John Wiley & Sons Inc

Access to resources Recommend Favorite